8 June 2009
In his presentations to the LAHA and International Fotona Meeting participants from over 40 countries around the world, he introduced the results of a pilot study in EVLA and presented on the treatment of hyperhidrosis using QCW Nd:YAG laser.
Presenting on the use of the XP-2 laser for EVLA and its effect to decrease post-procedure pain scores, Mark Whiteley discussed a pilot study which showed surprising results in comparison to the use of 810nm diode laser. In one segment of the study he performed EVLA procedures with the XP-2's 1064nm, QCW Nd:YAG laser on one side and a 810nm diode laser on the other. Patients reported pain and bruising lasting 2-3 weeks on the 810nm side and virtually no pain and bruising on the 1064nm, QCW Nd:YAG side. In a second study segment patients kept a pain diary, including a VAS assessment at day 3 post-op. In the 1064nm, QCW Nd:YAG group pain and bruising were significantly decreased and only 1 patient reported a haematoma. In a second presentation Mark Whiteley introduced hyperhidrosis and his experiences using the XP-2 laser's QCW Nd:YAG in laser sweat ablation procedures.
